BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Liangliang Xu, Peng Wang, Xinfu Feng, Jianwei Tang, Lian Li, Xiaobo Zheng, Jinfu Zhang, Yitao Hu, Tian Lan, Kefei Yuan, Yanfang Zhang, Shengsheng Ren, Xiangyong Hao, Ming Zhang, Mingqing Xu. SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinomaClinical Science 2019; 133(20): 2085 doi: 10.1042/CS20190666
2
Laith N. AL-Eitan, Doaa M. Rababa'h. Correlation between a variable number tandem repeat (VNTR) polymorphism in SMYD3 gene and breast cancer: A genotype-phenotype studyGene 2020; 728: 144281 doi: 10.1016/j.gene.2019.144281
3
Yong Liu, Xuegang Luo, Jingyu Deng, Yuan Pan, Li Zhang, Han Liang. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinomaTumor Biology 2015; 36(4): 2685 doi: 10.1007/s13277-014-2891-z
4
Aijun Liu, Yifan Liu, Bin Li, Ming Yang, Yang Liu, Junwu Su. Role of miR‐223‐3p in pulmonary arterial hypertension via targeting ITGB3 in the ECM pathway Cell Proliferation 2019; 52(2): e12550 doi: 10.1111/cpr.12550
5
Cinzia Bottino, Alessia Peserico, Cristiano Simone, Giuseppina Caretti. SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling PathwaysCancers 2020; 12(1): 142 doi: 10.3390/cancers12010142
6
Ioannis Anestopoulos, Georgia Persephoni Voulgaridou, Alexandros G. Georgakilas, Rodrigo Franco, Aglaia Pappa, Mihalis I. Panayiotidis. Epigenetic therapy as a novel approach in hepatocellular carcinomaPharmacology & Therapeutics 2015; 145: 103 doi: 10.1016/j.pharmthera.2014.09.005
7
Filipa Quintela Vieira, Pedro Costa-Pinheiro, Diogo Almeida-Rios, Inês Graça, Sara Monteiro-Reis, Susana Simões-Sousa, Isa Carneiro, Elsa Joana Sousa, Maria Inês Godinho, Fátima Baltazar, Rui Henrique, Carmen Jerónimo. SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3Oncotarget 2015; 6(15): 13644 doi: 10.18632/oncotarget.3767
8
Honggen Liu, Yong Liu, Fanming Kong, Wen Xin, Xiaojiang Li, Han Liang, Yingjie Jia. Elevated Levels of SET and MYND Domain-Containing Protein 3 Are Correlated with Overexpression of Transforming Growth Factor-β1 in Gastric CancerJournal of the American College of Surgeons 2015; 221(2): 579 doi: 10.1016/j.jamcollsurg.2015.02.023
9
Shinnosuke Suzuki, Yusuke Nozawa, Satoshi Tsukamoto, Takehito Kaneko, Hiroshi Imai, Naojiro Minami. Histone methyltransferase Smyd3 regulates early embryonic lineage commitment in miceREPRODUCTION 2015; 150(1): 21 doi: 10.1530/REP-15-0019
10
Ting-Ting Liu, Hui Xu, Wei-Ping Gao, Shu-Xiang Zhang, Xu-Hong Zhou, Juan Tang, Qiong-Na Liu. SET and MYND Domain-Containing Protein 3 (SMYD3) Polymorphism as a Risk Factor for Susceptibility and Poor Prognosis in Ovarian CancerMedical Science Monitor 2016; 22: 5131 doi: 10.12659/MSM.898095
11
Yong Liu, Jingyu Deng, Xuegang Luo, Yuan Pan, Li Zhang, Rupeng Zhang, Han Liang. Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancerMedical Oncology 2015; 32(1) doi: 10.1007/s12032-014-0404-y
12
Filipa Quintela Vieira, Pedro Costa-Pinheiro, João Ramalho-Carvalho, Andreia Pereira, Francisco Duarte Menezes, Luís Antunes, Isa Carneiro, Jorge Oliveira, Rui Henrique, Carmen Jerónimo. Deregulated expression of selected histone methylases and demethylases in prostate carcinomaEndocrine-Related Cancer 2014; 21(1): 51 doi: 10.1530/ERC-13-0375
13
Jing Li, Yun-Feng Piao, Zheng Jiang, Li Chen, Hai-Bo Sun. Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude miceWorld Journal of Gastroenterology 2009; 15(21): 2602-2608 doi: 10.3748/wjg.15.2602
14
Yong Liu, Honggen Liu, Xuegang Luo, Jingyu Deng, Yuan Pan, Han Liang. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancerTumor Biology 2015; 36(6): 4377 doi: 10.1007/s13277-015-3077-z
15
Gurukumari Rajajeyabalachandran, Swetha Kumar, Thanabal Murugesan, Shanthi Ekambaram, Ramya Padmavathy, Sooriya Kumar Jegatheesan, Ramesh Mullangi, Sriram Rajagopal. Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agentsExpert Opinion on Therapeutic Targets 2017; 21(2): 145 doi: 10.1080/14728222.2017.1272580
16
Lydia Hopp, Lilit Nersisyan, Henry Löffler-Wirth, Arsen Arakelyan, Hans Binder. Epigenetic Heterogeneity of B-Cell Lymphoma: Chromatin ModifiersGenes 2015; 6(4): 1076 doi: 10.3390/genes6041076
17
SHANG-WEN DONG, HAO ZHANG, BAO-LI WANG, PEI SUN, YUAN-GUO WANG, PENG ZHANG. Effect of the downregulation of SMYD3 expression by RNAi on RIZ1 expression and proliferation of esophageal squamous cell carcinomaOncology Reports 2014; 32(3): 1064 doi: 10.3892/or.2014.3307
18
Antonis Giakountis, Panagiotis Moulos, Michalis E. Sarris, Pantelis Hatzis, Iannis Talianidis. Smyd3-associated regulatory pathways in cancerSeminars in Cancer Biology 2017; 42: 70 doi: 10.1016/j.semcancer.2016.08.008
19
Shaodan Liu, Ziyue Sun, Yonghui Zhong, Qingxin Cui, Xuegang Luo, Yujie Dai. Advances in Applied BiotechnologyLecture Notes in Electrical Engineering 2015; 332: 399 doi: 10.1007/978-3-662-45657-6_42
20
Yu Wang, Bin-hui Xie, Wei-hao Lin, Yong-hui Huang, Jia-yan Ni, Jie Hu, Wei Cui, Jun Zhou, Long Shen, Lin-feng Xu, Fan Lian, He-ping Li. Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2Oncogene 2019; 38(25): 4948 doi: 10.1038/s41388-019-0766-x
21
Lian Yang, Jun He, Libo Chen, Guobin Wang. Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cellsMedical Oncology 2009; 26(4): 445 doi: 10.1007/s12032-008-9144-1
22
Michael J. Thomenius, Jennifer Totman, Darren Harvey, Lorna H. Mitchell, Thomas V. Riera, Kat Cosmopoulos, Alexandra R. Grassian, Christine Klaus, Megan Foley, Elizabeth A. Admirand, Haris Jahic, Christina Majer, Tim Wigle, Suzanne L. Jacques, Jodi Gureasko, Dorothy Brach, Trupti Lingaraj, Kip West, Sherri Smith, Nathalie Rioux, Nigel J. Waters, Cuyue Tang, Alejandra Raimondi, Michael Munchhof, James E. Mills, Scott Ribich, Margaret Porter Scott, Kevin W. Kuntz, William P. Janzen, Mikel Moyer, Jesse J. Smith, Richard Chesworth, Robert A. Copeland, P. Ann Boriack-Sjodin, Luis M. Schang. Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferationPLOS ONE 2018; 13(6): e0197372 doi: 10.1371/journal.pone.0197372
23
Chuanchao He, Junyao Xu, Jianlong Zhang, Dan Xie, Hua Ye, Zhiyu Xiao, Muyan Cai, Kang Xu, Yunjie Zeng, Haigang Li, Jie Wang. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinomaHuman Pathology 2012; 43(9): 1425 doi: 10.1016/j.humpath.2011.11.003
24
ZHEN QU, YONG JIANG, HUAN LI, DE-CAI YU, YI-TAO DING. Detecting abnormal methylation of tumor suppressor genes GSTP1, P16, RIZ1, and RASSF1A in hepatocellular carcinoma and its clinical significanceOncology Letters 2015; 10(4): 2553 doi: 10.3892/ol.2015.3536
25
Rozenn Josse, Julie Dumont, Alain Fautrel, Marie-Anne Robin, André Guillouzo. Identification of early target genes of aflatoxin B1 in human hepatocytes, inter-individual variability and comparison with other genotoxic compoundsToxicology and Applied Pharmacology 2012; 258(2): 176 doi: 10.1016/j.taap.2011.10.019
26
Mai Thanh Binh, Nghiem Xuan Hoan, Dao Phuong Giang, Hoang Van Tong, C.-Thomas Bock, Heiner Wedemeyer, Nguyen Linh Toan, Mai Hong Bang, Peter G. Kremsner, Christian G. Meyer, Le Huu Song, Thirumalaisamy P. Velavan. Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinomaScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59667-z
27
Fujia Lin, Danjuan Wu, Dan Fang, Yao Chen, Haitao Zhou, Caiwen Ou. STAT3-induced SMYD3 transcription enhances chronic lymphocytic leukemia cell growth in vitro and in vivoInflammation Research 2019; 68(9): 739 doi: 10.1007/s00011-019-01257-5
28
Sotirios C. Kampranis, Philip N. Tsichlis. Advances in Cancer Research 2009; 102: 103 doi: 10.1016/S0065-230X(09)02004-1
29
Carol-Ann Eberle, Margarita Zayas, Alexey Stukalov, Andreas Pichlmair, Gualtiero Alvisi, André C. Müller, Keiryn L. Bennett, Ralf Bartenschlager, Giulio Superti-Furga. The lysine methyltransferase SMYD3 interacts with hepatitis C virus NS5A and is a negative regulator of viral particle productionVirology 2014; : 34 doi: 10.1016/j.virol.2014.05.016